| TITLE |
DATE |
| Infinity and Mundipharma Extend Global Strategic Alliance |
29-Nov-2011 |
| Infinity Reports Third Quarter 2011 Financial Results |
8-Nov-2011 |
| Infinity Pharmaceuticals to Present at Piper Jaffray Health Care Conference |
7-Nov-2011 |
| Infinity Initiates Two Phase 1 Trials of IPI-145, a Potent Inhibitor of PI3K Delta and Gamma |
31-Oct-2011 |
| Infinity Announces the Date of Its Third Quarter 2011 Financial Results Conference Call and Webcast |
27-Oct-2011 |
| Infinity Pharmaceuticals Announces Its Participation at Two Investor Conferences |
26-Oct-2011 |
| Infinity Completes Enrollment in Phase 2 Trial of IPI-926, an Oral
Smoothened Antagonist, in Pancreatic Cancer and Provides Additional
Program Updates |
17-Oct-2011 |
| Infinity Pharmaceuticals to Present at BioCentury NewsMakers Conference |
12-Oct-2011 |
| Infinity Pharmaceuticals to Present at UBS Conference |
13-Sep-2011 |
| Infinity Pharmaceuticals to Present at Two Upcoming Conferences |
30-Aug-2011 |
| Infinity Reports Second Quarter 2011 Financial Results |
9-Aug-2011 |
| Infinity Announces the Date of Its Second Quarter 2011 Financial Results Conference Call and Webcast |
2-Aug-2011 |
| Infinity Expands Clinical Development Program for IPI-926, an Oral Smoothened Antagonist Targeting the Hedgehog Pathway |
22-Jun-2011 |
| Infinity Presents Data on Retaspimycin Hydrochloride, a Novel Hsp90 Inhibitor, in Non-Small Cell Lung Cancer at ASCO Meeting |
6-Jun-2011 |
| Infinity Reports Results From Phase 1b Clinical Trial of IPI-926, an Oral Smoothened Antagonist, in Pancreatic Cancer at ASCO Meeting |
4-Jun-2011 |
| Infinity to Highlight Clinical Progress and Review Abstracts to be Presented at ASCO Annual Meeting |
1-Jun-2011 |
| Infinity Pharmaceuticals to Present at Jefferies Conference |
31-May-2011 |
| Infinity Announces Clinical Data to be Presented at ASCO |
19-May-2011 |
| Infinity Initiates Randomized Phase 2 Trial of IPI-504, a Novel Hsp90 Inhibitor, in Non-Small Cell Lung Cancer |
19-May-2011 |
| Infinity Reports First Quarter 2011 Financial Results |
10-May-2011 |
| Infinity Announces the Date of Its First Quarter 2011 Financial Results Conference Call and Webcast |
3-May-2011 |
| Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development |
11-Apr-2011 |
| Infinity Pharmaceuticals to Present at BioCentury Future Leaders Conference |
7-Apr-2011 |
| Infinity Reports New Preclinical Data for IPI-926 at AACR Supporting Development in Chondrosarcoma |
3-Apr-2011 |
| Infinity to Present New Preclinical Data on IPI-926, a Novel Smoothened Antagonist Targeting the Hedgehog Pathway, at Upcoming AACR Meeting |
23-Mar-2011 |
| Infinity Provides Company Update and Reports Fourth Quarter and Full-Year 2010 Financial Results |
15-Mar-2011 |
| Infinity Announces the Date of Its Fourth Quarter 2010 Financial Results Conference Call and Webcast |
8-Mar-2011 |
| Infinity Initiates Phase 2 Trial of IPI-926 in Patients With Chondrosarcoma |
3-Mar-2011 |
| Infinity Pharmaceuticals to Present at Two Upcoming Conferences |
28-Feb-2011 |
| Infinity Initiates Phase 2 Portion of Trial of IPI-926 in Pancreatic Cancer |
22-Feb-2011 |
| Infinity Provides 2011 Goals and Guidance |
7-Jan-2011 |
| Infinity Pharmaceuticals to Present at 29th Annual J.P. Morgan Healthcare Conference |
5-Jan-2011 |
| Infinity Elevated to NASDAQ Global Select Market |
3-Jan-2011 |
| Infinity and Mundipharma Extend Global Strategic Alliance |
13-Dec-2010 |
| Infinity Pharmaceuticals to Present at Piper Jaffray Healthcare Conference |
22-Nov-2010 |
| Infinity Pharmaceuticals to Present at Lazard Healthcare Conference |
10-Nov-2010 |
| Infinity Provides Company Update and Reports Third Quarter 2010 Financial Results |
9-Nov-2010 |
| Infinity Augments Executive Leadership Team, Appointing New Chief Medical Officer and New Vice President, Product Development and Medical Affairs |
8-Nov-2010 |
| Infinity Awarded Approximately $750,000 in Grants for Qualifying Therapeutic Development Projects |
4-Nov-2010 |
| Infinity Announces That Purdue Pharmaceutical Products L.P. and Mundipharma International Corporation Ltd. Exercise Rights to Develop and Commercialize Infinity's FAAH Pain Program Worldwide |
26-Oct-2010 |
| Infinity Announces the Date of Its Third Quarter 2010 Financial Results Conference Call and Webcast |
25-Oct-2010 |
| Results Showing Activity of IPI-504 in Patients With Non-Small Cell Lung Cancer Published in Journal of Clinical Oncology |
14-Oct-2010 |
| Infinity Announces Promising Phase 1 Data of IPI-926 in Patients With Advanced or Metastatic Solid Tumors |
10-Oct-2010 |
| Infinity Pharmaceuticals to Present Phase 1 Clinical Data of IPI-926 at ESMO Congress |
22-Sep-2010 |
| Infinity Pharmaceuticals to Present at Two Upcoming Conferences |
8-Sep-2010 |
| Infinity Highlights R&D Progress and Announces Second Quarter 2010 Financial Results |
4-Aug-2010 |
| Infinity to Present at BMO Healthcare Conference |
29-Jul-2010 |
| Infinity Announces Second Quarter 2010 Results Conference Call |
28-Jul-2010 |
| Infinity and Intellikine Enter Agreement to Develop Oral Therapies Targeting PI3 Kinase Delta, Gamma |
8-Jul-2010 |
| Infinity Initiates Second Clinical Trial of IPI-493, Its Oral Hsp90 Chaperone Inhibitor |
24-Jun-2010 |
| Infinity Reports Results From Phase 2 Clinical Trial of IPI-504 in Non-Small Cell Lung Cancer |
4-Jun-2010 |
| Infinity to Present at Jefferies Global Life Sciences Conference |
2-Jun-2010 |
| Infinity Announces Addition to Senior Leadership Team |
24-May-2010 |
| Infinity to Present Data From Its Anti-Cancer Programs at ASCO Meeting |
20-May-2010 |
| Infinity Announces Senior Management Promotion |
18-May-2010 |
| Infinity Reports R&D Highlights and Announces First Quarter 2010 Financial Results |
6-May-2010 |
| Infinity Announces May 6 Webcast of First Quarter 2010 Financial Results Conference Call |
29-Apr-2010 |
| Infinity Initiates Randomized Clinical Trial of IPI-926 in Pancreatic Cancer and Reports New Preclinical Data at AACR |
21-Apr-2010 |
| Infinity to Present New Preclinical Data From Its Hedgehog Pathway Inhibitor Program at AACR Meeting |
8-Apr-2010 |
| Infinity's Innovative Hedgehog Pathway Inhibitor Program to be Highlighted at Upcoming Conferences |
10-Mar-2010 |
| Infinity to Present at Cowen Health Care Conference |
2-Mar-2010 |
| Infinity Announces Presentations at Upcoming Lung Cancer Meeting |
23-Feb-2010 |
| Infinity Initiates Clinical Development of Its Fourth Drug Candidate and Announces 2009 Financial Results |
10-Feb-2010 |
| Infinity Announces 2009 Financial Results Conference Call |
3-Feb-2010 |
| Infinity Announces Updated Presentation Time at the J.P. Morgan Healthcare Conference |
11-Jan-2010 |
| Infinity Announces Key 2010 Objectives |
11-Jan-2010 |
| Infinity Announces Presentations at January Conferences |
7-Jan-2010 |
| Infinity Names Adelene Q. Perkins Chief Executive Officer |
7-Dec-2009 |
| Infinity's IPI-504 Named One of Windhover and Campbell Alliance's "Top 10 Projects to Watch" in Oncology |
17-Nov-2009 |
| Adelene Q. Perkins Named "Best Executive" at Annual Stevie(R) Awards Ceremony |
16-Nov-2009 |
| Infinity to Present at Upcoming Conferences |
10-Nov-2009 |
| Infinity Reports Recent R&D Highlights and Third Quarter 2009 Results |
9-Nov-2009 |
| Infinity Announces Third Quarter 2009 Results Conference Call |
2-Nov-2009 |
| Infinity Announces Appointment of Dr. Thomas J. Lynch to Its Board of Directors |
7-Oct-2009 |
| Infinity to Present At Upcoming Conferences |
2-Sep-2009 |
| Infinity Reports Recent R&D Highlights and Second Quarter 2009 Results |
5-Aug-2009 |
| Infinity Announces Second Quarter 2009 Results Conference Call |
30-Jul-2009 |
| Infinity Paper On Discovery of Its Novel Hedgehog Inhibitor, IPI-926, Published in Journal of Medicinal Chemistry |
23-Jul-2009 |
| Infinity Pharmaceuticals Added to Russell 2000(r) Index |
29-Jun-2009 |
| Infinity Reports Encouraging Clinical Data for IPI-504 at ASCO 2009 |
30-May-2009 |
| New Paper in Science Features Infinity's IPI-926 Hedgehog Pathway Inhibitor as a Promising New Approach in Chemo-Resistant Pancreatic Cancer |
29-May-2009 |
| Infinity Pharmaceuticals Named Winner of The Scientist's 'Best Places to Work in Industry' and Featured in Boston Business Journal's Best Places to Work 2009 Survey |
27-May-2009 |
| Clinical Data From Infinity's Hsp90 Chaperone Inhibitor Program to be Presented During ASCO Meeting |
13-May-2009 |
| Infinity Reports Recent Pipeline Developments and First Quarter 2009 Results |
4-May-2009 |
| Infinity Announces First Quarter 2009 Results Conference Call |
28-Apr-2009 |
| Infinity Presents Preclinical Data Demonstrating Potential of Hedgehog Pathway Inhibition With IPI-926 in Multiple Cancer Settings |
21-Apr-2009 |
| Infinity Presents New Preclinical Data From Its Heat Shock Protein 90 Inhibitor Program At AACR |
21-Apr-2009 |
| Infinity Halts RING Trial in Advanced Gastrointestinal Stromal Tumors |
15-Apr-2009 |
| Infinity Announces Leadership Promotions |
7-Apr-2009 |
| Infinity Initiates International Phase 2 Trial of IPI-504 in Combination With Herceptin(r) in Patients With HER2-Positive Breast Cancer |
30-Mar-2009 |
| Infinity Presents the Chemistry and Discovery of IPI-926, Its Novel Hedgehog Signaling Pathway Inhibitor, At ACS Meeting |
25-Mar-2009 |
| Infinity to Present At the Future Leaders Conference |
23-Mar-2009 |
| Infinity to Present the Discovery of IPI-926, Its Hedgehog Signaling Pathway Inhibitor, At ACS Meeting |
17-Mar-2009 |
| Infinity to Present At Upcoming Conferences |
3-Mar-2009 |
| Infinity Announces Hedgehog Pathway Preclinical Data in Ovarian Cancer |
9-Feb-2009 |
| Infinity Well-Financed to Achieve 'I4 2012' Long-Term Goals; Announces 2008 Financial Results |
9-Feb-2009 |
| Infinity Announces Conference Call Discussing Fourth Quarter 2008 Results |
2-Feb-2009 |
| Infinity Announces 2009 and Long-Term Goals, Building On 2008 Success |
12-Jan-2009 |
| Infinity Announces Completion of Second Equity Investment by Purdue |
8-Jan-2009 |
| Infinity to Present At JP Morgan Healthcare Conference |
6-Jan-2009 |
| Infinity Reacquires Worldwide Rights to Its Hsp90 Inhibitor Program |
11-Dec-2008 |
| Infinity Reacquires Worldwide Rights to Its Hsp90 Inhibitor Program |
11-Dec-2008 |
| Infinity to Present At Piper Jaffray 20th Annual Health Care Conference |
26-Nov-2008 |
| Infinity Announces Global Strategic Alliance With Purdue Pharma and Mundipharma Encompassing Infinity's Early Clinical and Discovery Programs |
20-Nov-2008 |
| Infinity to Present At Rodman & Renshaw Annual Global Investment Conference |
5-Nov-2008 |
| Infinity Announces Expansion of Phase 2 Clinical Study Evaluating IPI-504 in Advanced Non-Small Cell Lung Cancer |
29-Oct-2008 |
| Infinity Advances Its Oncology Portfolio and Announces Third Quarter Financial Results |
29-Oct-2008 |
| Infinity Announces the Promotion of Adelene Q. Perkins to President and Chief Business Officer |
28-Oct-2008 |
| Infinity's Hedgehog Pathway Inhibitor IPI-926 Demonstrates Significant Tumor Growth Inhibition in Human Pancreatic Cancer Model |
24-Oct-2008 |
| INFINITY INITIATES INTERNATIONAL PHASE 3 REGISTRATION TRIAL OF IPI-504 IN PATIENTS WITH REFRACTORY GIST |
24-Oct-2008 |
| Infinity Announces Conference Call Discussing R&D Progress and Third Quarter 2008 Results |
23-Oct-2008 |
| Preclinical Data Show Anti-Tumor Activity With Infinity's Oral Hsp90 Inhibitor IPI-493 |
22-Oct-2008 |
| Infinity Initiates Phase 1 Trial Of Novel Hedgehog Pathway Inhibitor, IPI-926 |
16-Oct-2008 |
| INFINITY TO PRESENT NEW DATA ON ITS PROPRIETARY ANTI-CANCER AGENTS AT AACR-EORTC-NCI SYMPOSIUM |
14-Oct-2008 |
| Infinity to Present At Upcoming Conferences |
28-Aug-2008 |
| Infinity Highlights Clinical Advances in Its Portfolio of Anti-Chaperone Agents and Announces Second Quarter Financial Results |
4-Aug-2008 |
| Infinity Initiates Clinical Development of IPI-493, Its Oral Anti-Chaperone Agent, in Patients With Advanced Solid Tumors |
30-Jul-2008 |
| Infinity Announces Conference Call Discussing R&D Progress and Second Quarter 2008 Results |
28-Jul-2008 |
| Infinity Announces the Addition of Two New Board Members and Leadership Promotions |
22-Jul-2008 |
| Infinity Provides Update On Phase 2 Signal-Finding Clinical Study of IPI-504 in Advanced Prostate Cancer |
14-Jul-2008 |
| Infinity Pharmaceuticals Named as One of the Best Places to Work |
9-Jul-2008 |
| Infinity to Present at Upcoming Conferences |
6-Jun-2008 |
| Infinity Announces Clinical Data Confirming Activity and Safety of IPI-504, a Novel Hsp90 Inhibitor, in Patients With Refractory GIST |
31-May-2008 |
| Infinity Announces Oral Presentation of Results From Clinical Trial of IPI-504 in Patients With GIST At ASCO Annual Meeting |
16-May-2008 |
| Infinity Highlights Promising Preclinical Hedgehog Data and Announces First Quarter Financial Results |
5-May-2008 |
| Infinity Announces Conference Call Discussing R&D Progress and First Quarter 2008 Results |
28-Apr-2008 |
| Infinity to Present At Morgan Stanley Global Healthcare Unplugged Conference |
25-Apr-2008 |
| Preclinical Data Highlighting Potential of Retaspimycin in Treating Non-Small Cell Lung Cancer With Acquired Drug Resistance Presented by Infinity and MedImmune At AACR |
15-Apr-2008 |
| Infinity's Hedgehog Antagonist Delays Tumor Growth Following Chemotherapy in Preclinical Model of Small Cell Lung Cancer; Data Presented At AACR |
15-Apr-2008 |
| New Preclinical Data Show Significant Anti-Tumor Activity Associated With Infinity's Hedgehog Antagonist IPI-926 |
13-Apr-2008 |
| New Data On Infinity's Lead Anti-Cancer Candidates to be Presented At AACR |
7-Apr-2008 |
| Infinity to Present At Cowen Annual Health Care Conference |
11-Mar-2008 |
| Infinity Highlights Broad Expansion of Hsp90 Clinical Program and Announces Fourth Quarter Financial Results |
13-Feb-2008 |
| Infinity to Present At Roth Annual OC Growth Stock Conference |
12-Feb-2008 |
| Infinity Announces Conference Call Discussing Fourth Quarter and Year End 2007 Results |
7-Feb-2008 |
| Infinity and MedImmune Announce Approval for Generic Name for Novel Hsp90 Inhibitor |
4-Feb-2008 |
| Infinity Reviews 2007 Achievements and Announces 2008 Goals |
7-Jan-2008 |
| Infinity and MedImmune Initiate Phase 1b Trial of IPI-504 in Combination With Taxotere in Patients With Advanced Solid Tumor Cancers |
4-Jan-2008 |
| Infinity Announces Updated Presentation Time At the JPMorgan Healthcare Conference |
3-Jan-2008 |
| Infinity and MedImmune Initiate Phase 2 Trial of IPI-504 to Assess the Hsp90 Inhibitor's Potential Anti-Tumor Activity in Patients With Advanced Non-Small Cell Lung Cancer |
19-Dec-2007 |
| Infinity to Present At the 2008 JPMorgan Healthcare Conference |
17-Dec-2007 |
| Infinity to Present At Piper Jaffray Health Care Conference |
20-Nov-2007 |
| Infinity and MedImmune Initiate Phase 2 Clinical Trial of IPI-504, a Novel Hsp90 Inhibitor, in Patients With Advanced Hormone-Refractory Prostate Cancer |
13-Nov-2007 |
| Infinity Announces Hedgehog Pathway Inhibitor Agreement With AstraZeneca |
12-Nov-2007 |
| Infinity to Present At Acumnet Biofin Rodman & Renshaw Healthcare Conference |
30-Oct-2007 |
| Infinity Announces Advancement of Lead Development Program and Third Quarter Financial Results |
29-Oct-2007 |
| Infinity and MedImmune Present Preliminary Phase 1 Data Demonstrating Biological Activity of IPI-504, A Novel Hsp90 Inhibitor, in Advanced Non-Small Cell Lung Cancer |
25-Oct-2007 |
| Infinity Announces Conference Call Discussing Third Quarter 2007 Results |
23-Oct-2007 |
| Infinity and MedImmune Announce Issuance of U.S. Patent for Proprietary Heat Shock Protein 90 Inhibitors |
23-Oct-2007 |
| Infinity to Present at 2007 Bio Investor Forum |
3-Oct-2007 |
| Infinity to Present At UBS Global Life Sciences Conference |
19-Sep-2007 |
| Infinity and MedImmune Receive Orphan Drug Designation for IPI-504 for Treatment of Gastroinstestinal Stromal Tumors |
17-Sep-2007 |
| Infinity Announces Second Quarter Results and Highlights Recent Accomplishments |
1-Aug-2007 |
| Infinity Announces Conference Call Discussing Second Quarter 2007 Results |
26-Jul-2007 |
| Infinity to Present At Jefferies Healthcare Conference |
22-Jun-2007 |
| Infinity to Present At Piper Jaffray Health Care Conference |
14-Jun-2007 |
| Infinity to Present At Needham Biotechnology & Medical Technology Conference |
7-Jun-2007 |
| Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting |
5-Jun-2007 |
| Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO |
31-May-2007 |
| Infinity to Present At Banc of America Health Care Conference |
30-May-2007 |
| Infinity to Participate in Panels At BIO International Convention |
4-May-2007 |
| Infinity Announces First Quarter Results and Highlights Recent Accomplishments |
30-Apr-2007 |
| Infinity Announces Conference Call Discussing First Quarter 2007 Results |
24-Apr-2007 |
| Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR |
10-Apr-2007 |
| Infinity Announces Corporate Governance Proposal For Annual Election of Directors |
20-Mar-2007 |
| Infinity to Present At Susquehanna International Group Healthcare Conference |
23-Feb-2007 |
| Infinity and MedImmune Initiate Phase I/II Clinical Trial of IPI-504 for Patients With Non-Small Cell Lung Cancer |
14-Feb-2007 |
| Infinity Announces Fourth Quarter and Year End 2006 Results |
7-Feb-2007 |
| Infinity to Present At 9th Annual BIO CEO & Investor Conference |
6-Feb-2007 |
| Infinity Announces Conference Call Discussing Fourth Quarter and Year End 2006 Results |
1-Feb-2007 |
| Infinity Receives Corporate Vision Award From Gilda's Club New York City |
26-Jan-2007 |
| Infinity Reviews 2006 Achievements and Announces Product and Business Goals for 2007 |
8-Jan-2007 |
| Infinity Presentation At the JPMorgan Healthcare Conference Rescheduled to Monday, January 8, 2007 At 8:00 a.m. PST |
4-Jan-2007 |
| Infinity to Present At the JPMorgan Healthcare Conference |
2-Jan-2007 |
| Infinity Announces Panel Participation at RBC Capital Markets 2006 Healthcare Conference |
8-Dec-2006 |
| Infinity Announces Third Quarter 2006 Results and Highlights Recent Accomplishments |
9-Nov-2006 |
| Infinity and MedImmune Announce Promising Biological Activity of Anti-Hsp90 Compound in Phase I GIST Trial |
7-Nov-2006 |
| Infinity Announces Presentations / Webcasts at Cowen & Co., CIBC World Markets, and Rodman & Renshaw Conferences |
31-Oct-2006 |
| Infinity to Present at the UBS Global Life Sciences Conference |
22-Sep-2006 |
| Infinity Pharmaceuticals Announces Three Key Strategic Hires |
21-Sep-2006 |
| Infinity Pharmaceuticals Announces Completion of Merger with Discovery Partners International |
13-Sep-2006 |
| Discovery Partners International Announces Stockholder Approval of the Infinity Merger |
12-Sep-2006 |
| Infinity Pharmaceuticals Announces Conference Call to Discuss Results of Merger Vote |
11-Sep-2006 |
| Discovery Partners International Announces 4-to-1 Reverse Stock Split Effective Immediately Prior to the Closing of the Infinity Merger |
8-Sep-2006 |
| Infinity Pharmaceuticals Announces Filing of Proxy Statement/Prospectus Supplement for Proposed Merger With Discovery Partners International |
28-Aug-2006 |
| MedImmune and Infinity Pharmaceuticals Announce Cancer Drug Development and Worldwide Commercialization Agreement |
28-Aug-2006 |
| Discovery Partners International Announces Filing of Supplement to Joint Proxy Statement/Prospectus |
28-Aug-2006 |
| Discovery Partners International Reports Second Quarter 2006 Results |
9-Aug-2006 |
| Infinity Pharmaceuticals Announces Effectiveness of Registration Statement For The Proposed Merger with Discovery Partners International |
8-Aug-2006 |
| Discovery Partners International Announces Record Date for Stockholders Eligible to Vote on Merger |
27-Jul-2006 |
| Current Issue of Journal of Medicinal Chemistry Highlights Advantages of Infinity's Lead Oncology Drug Candidate, IPI-504 |
27-Jul-2006 |
| Infinity Announces Extension of Amgen Agreement |
20-Jul-2006 |
| Discovery Partners International Announces Completion of Sale of Drug Discovery Service Operations |
6-Jul-2006 |
| Galapagos to Acquire Drug Discovery Service Operations of Discovery Partners International |
13-Jun-2006 |
| Discovery Partners International Reports First Quarter 2006 Results |
4-May-2006 |
| Discovery Partners International to Announce First Quarter 2006 Financial Results |
25-Apr-2006 |
| Infinity Announces Corporate Development Conference Call |
12-Apr-2006 |
| Discovery Partners International and Infinity Pharmaceuticals Announce Merger Agreement |
12-Apr-2006 |
| Discovery Partners International Conference Call to Announce Corporate Developments |
12-Apr-2006 |
| Infinity President and Chief Scientific Officer Receives 25th AACR-Bruce F. Cain Award |
5-Apr-2006 |
| Infinity Announces Three Leadership Promotions |
30-Mar-2006 |
| Infinity Announces Major Drug Discovery, Development and Commercialization Alliance in Oncology |
6-Mar-2006 |
| Discovery Partners International Reports Fourth Quarter and Full Year 2005 Results |
21-Feb-2006 |
| Discovery Partners International Conference Call to Announce Fourth Quarter and Year End 2005 Financial Results |
9-Feb-2006 |
| Infinity Initiates Phase I Clinical Trial of IPI-504 for Patients with Gastrointestinal Stromal Tumors (GIST) |
10-Jan-2006 |
| Infinity to Present at 24th Annual JPMorgan Healthcare Conference on Tuesday, January 10, 2006 |
3-Jan-2006 |
| Discovery Partners International Announces Termination of New Collaboration Discussions With Pfizer Inc and Consolidation of Chemistry Operations |
29-Nov-2005 |
| Discovery Partners International Announces Resignation of Chairman and Chief Executive Officer |
14-Nov-2005 |
| Discovery Partners International Announces Receipt of Success Milestone Payment in Its Lead Finding Collaboration With Seikagaku Corporation |
9-Nov-2005 |
| Discovery Partners International Reports Third Quarter 2005 Results |
1-Nov-2005 |
| Discovery Partners International Announces Achievement of Milestones in Multi-Target Drug Discovery Collaboration |
31-Oct-2005 |
| Discovery Partners International, Inc. Announces Drug Discovery Collaboration With Mitsubishi Pharma Corporation |
26-Oct-2005 |
| Discovery Partners International, Inc. Announces Significant Discovery Collaboration With Ono Pharmaceutical Co., Ltd. |
24-Oct-2005 |
| Discovery Partners International Conference Call to Announce Third Quarter 2005 Financial Results |
18-Oct-2005 |
| Discovery Partners International, Inc. Announces the Sale of Its Discovery Systems Business to Nexus Biosystems, Inc. |
14-Oct-2005 |
| Discovery Partners International Reports Second Quarter 2005 Results |
2-Aug-2005 |
| Discovery Partners International Conference Call to Announce Second Quarter 2005 Financial Results |
19-Jul-2005 |
| Discovery Partners International Reports First Quarter 2005 Results |
3-May-2005 |
| Discovery Partners International Conference Call to Announce First Quarter 2005 Financial Results |
19-Apr-2005 |
| Discovery Partners International Announces Appointment of Chief Scientific Officer |
6-Apr-2005 |
| Discovery Partners International, Inc. and Chroma Therapeutics Entered Into a Collaboration for Lead Identification on Multiple Targets |
29-Mar-2005 |
| NascaCell and Discovery Partners International Enter Co-Marketing Agreement |
21-Mar-2005 |
| Discovery Partners International, Inc.'S Chief Executive Officer to Present at SG Cowen & Co. 25th Annual Health Care Conference |
10-Mar-2005 |
| Discovery Partners International Reports Fourth Quarter and Full Year 2004 Results With Record Profit From Operations |
1-Mar-2005 |
| Discovery Partners International Announce Signing of Binding Letter of Intent to Acquire Biofrontera Discovery GmbH |
1-Mar-2005 |
| Discovery Partners International, Inc. and Bruker AXS Inc. Announce New Bench Top Protein Crystallization System |
28-Feb-2005 |
| Discovery Partners International Conference Call to Announce Fourth Quarter and Year End 2004 Financial Results |
23-Feb-2005 |
| Discovery Partners International, Inc. Announces New ADME & Safety Profiling Services |
31-Jan-2005 |
| Biovitrum AB and Discovery Partners International, Inc. Form Research Alliance |
14-Dec-2004 |
| Discovery Partners International, Inc.'s Chief Executive Officer to Present at the SG Cowen & Co. 5th Annual Global Health Care Conference |
9-Nov-2004 |
| Discovery Partners International Reports Third Quarter 2004 Results |
2-Nov-2004 |
| Discovery Partners International Conference Call to Announce Third Quarter 2004 Financial Results |
19-Oct-2004 |
| Discovery Partners International, Inc.'s Chief Executive Officer and Chief Financial Officer to Present at Merriman Curhan Ford & Co. Investor Summit 2004 |
13-Sep-2004 |
| Discovery Partners International, Inc.'s Chief Executive Officer and Chief Financial Officer to Present at New York Growth Stock Conference |
8-Sep-2004 |
| Discovery Partners International, Inc.'s Chief Executive Officer and Chief Financial Officer to Present at Wall Street Analyst Conference |
7-Sep-2004 |
| NIH Awards Discovery Partners International, Inc. Major Multi-Year Contract to Build Small Molecule Repository of Up to 1 Million Compounds as Part of NIH Roadmap Initiative |
23-Aug-2004 |
| Discovery Partners International Reports Second Quarter 2004 Results |
20-Jul-2004 |
| Discovery Partners International Conference Call to Announce Second Quarter 2004 Financial Results |
6-Jul-2004 |
| Discovery Partners International, Inc. Announces Exercise of Over-Allotment Option |
14-May-2004 |
| Discovery Partners International, Inc. Announces Pricing of Public Offering |
6-May-2004 |
| Discovery Partners International Reports First Quarter 2004 Results |
20-Apr-2004 |
| Discovery Partners International, Inc. Announces Collaboration With Vertex
Pharmaceuticals |
19-Apr-2004 |
| Discovery Partners International Conference Call
to Announce First Quarter 2004 Financial Results |
6-Apr-2004 |
| Discovery Partners International, Inc. Files Registration Statement |
10-Mar-2004 |
| Discovery Partners International, Inc. Announces Broadened Collaboration
Agreement With Pfizer Inc |
18-Feb-2004 |
| Discovery Partners International, Inc.'s Chief Executive Officer and Chief
Financial Officer to Present at Roth Capital Partners 16th Annual Growth Stock
Conference |
11-Feb-2004 |
| Discovery Partners International Reports Fourth Quarter and Year 2003 Results
With Record Net Income and Profit From Operations |
10-Feb-2004 |
| Discovery Partners International, Inc. and Celltech Enter Into Lead Finding Collaboration |
4-Feb-2004 |
| Discovery Partners International, Inc.'s Chief Executive Officer to Present at
UBS Global Healthcare Services Conference |
29-Jan-2004 |
| Discovery Partners International Conference Call to Announce Fourth Quarter
and Year End 2003 Financial Results |
27-Jan-2004 |
| Discovery Partners International Announces the Election of Herm Rosenman
To DPII's Board of Directors |
8-Dec-2003 |
| Discovery Partners International, Inc. and Allergan Enter Into
Lead Finding Collaboration |
4-Dec-2003 |
| Discovery Partners International Reports Third Quarter 2003 Results With
Record Net Income and Profit From Operations |
21-Oct-2003 |
| Discovery Partners International, Inc. Announces Expansion of Collaboration
With Inspire Pharmaceuticals for the Optimization of Lead Compounds |
20-Oct-2003 |
| Discovery Partners International, Inc. Conference Call
To Announce Third Quarter 2003 Financial Results |
7-Oct-2003 |
| Discovery Partners International, Inc. and AstraZeneca UK Limited
Sign Gene Expression Profiling License Agreement |
25-Sep-2003 |
| Discovery Partners International, Inc.'s Chief Executive Officer
to Present at Wall Street Analyst Forum |
11-Sep-2003 |
| Discovery Partners International, Inc.'s Chief Executive Officer to Present
At Roth Capital Partners New York Conference |
8-Sep-2003 |
| Discovery Partners International, Inc. and Kyorin Pharmaceutical Co., Inc.
Sign Drug Discovery Agreement |
2-Sep-2003 |
| Discovery Partners International, Inc. and Bruker AXS Inc. Announce Strategic Alliance and Distribution Agreement |
25-Jul-2003 |
| Discovery Partners International Reports Second Quarter 2003 Results |
22-Jul-2003 |
| Discovery Partners International, Inc. Conference Call to Announce Second Quarter 2003 Financial Results |
8-Jul-2003 |
| Discovery Partners International, Inc. Invited to Present at the Gordon Research Combinatorial Chemistry Conference 2003 |
8-Jul-2003 |
| Discovery Partners International, Inc. Announces Lead Finding Collaboration With Seikagaku Corporation |
30-Jun-2003 |
| Actelion to Further Strengthen Its Research Efforts Long-term Collaboration With Discovery Partners International Grants Access to Highly Qualified Staff and Unique Biological Screening Methods |
2-Jun-2003 |
| Discovery Partners International Reports First Quarter 2003 Results With Record Revenues and Profitability |
22-Apr-2003 |
| Discovery Partners International, Inc. Conference Call to Announce First Quarter 2003 Financial Results |
9-Apr-2003 |
| Discovery Partners International, Inc. Adopts Shareholder Rights Plan |
14-Feb-2003 |
| Discovery Partners International Announces Lead Finding Collaboration With Novartis Pharma AG |
13-Feb-2003 |
| Discovery Partners International Reports Fourth Quarter 2002 Results With Record Revenues |
11-Feb-2003 |
| Discovery Partners International, Inc. Announces Significant Agreement With Glaxo SmithKline to Deliver Next Generation Chemistry Synthesis Platform |
6-Feb-2003 |
| Discovery Partners International, Inc. Conference Call To Announce Fourth Quarter |
28-Jan-2003 |
| Discovery Partners International, Inc. Introduces Integrated System for High Throughput Protein Crystallization |
27-Jan-2003 |
| Discovery Partners International, Inc. Announces the Appointment of Douglas |
12-Dec-2002 |
| Discovery Partners International, Inc. Enters Into a License and Development Agreement With Mimotopes Pty. Ltd. and Expands Distribution of IRORI Combinatorial Chemistry Products |
25-Nov-2002 |
| Discovery Partners Reports Third Quarter 2002 Financial Results |
22-Oct-2002 |
| Discovery Partners International, Inc. and Theracos, Inc. Announce Extension |
22-Oct-2002 |
| Discovery Partners International Conference Call to Announce Third Quarter |
8-Oct-2002 |
| Discovery Partners International's Chief Executive Officer to Present at UBS |
30-Sep-2002 |
| Inspire Pharmaceuticals and Discovery Partners International Enter Into Collaboration |
6-Aug-2002 |
| Discovery Partners Reports Second Quarter 2002 Financial Results |
23-Jul-2002 |
| Discovery Partners International Conference Call to Announce Second Quarter 2002 Financial Results |
11-Jul-2002 |
| Discovery Partners International Announces the Appointment of Taylor J. Crouch To the Position of President and Chief Operating Officer |
9-Jul-2002 |
| Discovery Partners International Reports Financial Results For First Quarter 2002 |
23-Apr-2002 |
| Discovery Partners International Announces First Quarter 2002 Financial Results Conference Call and Live Public Webcast |
18-Apr-2002 |
| Discovery Partners International Announces Significant Drug Discovery Collaboration Discovery Partners to Provide Lead Optimization Services For Metabolic Syndrome |
16-Apr-2002 |
| Discovery Partners International's Chief Executive Officer to Present Keynote |
4-Mar-2002 |
| Discovery Partners International Presents at Lehman Brothers 5th Annual Global Healthcare Services Conference Wednesday, February 27, 2002 at 9:00 a.m. Eastern Time |
25-Feb-2002 |
| Discovery Partners International, Inc. Reports Fourth Quarter and Year End Results In Line with Previously Issued Financial Guidance |
12-Feb-2002 |
| Discovery Partners International Presents at UBS Warburg Global Healthcare |
1-Feb-2002 |
| Discovery Partners International Presents at 20th Annual JPMorgan H&Q Healthcare |
4-Jan-2002 |
| Discovery Partners International Announces Major Chemistry Collaboration With |
20-Dec-2001 |
| Discovery Partners International Issues Statement |
30-Nov-2001 |
| Discovery Partners International Establishes European Headquarters in Basel, |
28-Nov-2001 |
| Discovery Partners International Announces a Significant Expansion Of Its Agreement |
27-Nov-2001 |
| Discovery Partners International Announces Appointment of New Chief Financial Officer |
8-Nov-2001 |
| Discovery Partners Reports Third Quarter 2001 Financial Results |
30-Oct-2001 |
| Discovery Partners International Initiates Chemistry Collaboration With DuPont |
25-Oct-2001 |
| Discovery Partners International Announces Major Chemistry Collaboration With Merck |
22-Oct-2001 |
| Discovery Partners Announces Stock Repurchase Program And Updates Business Outlook For Third and Fourth Quarters of 2001 |
8-Oct-2001 |
| Discovery Partners International and the Genetics Company Enter Research Collaboration |
24-Sep-2001 |
| Discovery Partners Reports Second Quarter 2001 Financial Results |
31-Jul-2001 |
| Discovery Partners and MAXIA Announce Successful Completion of Drug Discovery |
18-Jul-2001 |
| Discovery Partners International Announces Election of Directors |
6-Jun-2001 |
| Discovery Partners International, Inc. Completes Acquisition of Xenometrix, Inc. |
8-May-2001 |
| Discovery Partners International Presents At Dain Rauscher Wessels 2nd Annual ``Genes to Drugs'' Genomics and Life Sciences Conference |
4-May-2001 |
| Discovery Partners Reports Financial Results for First Quarter 2001 |
1-May-2001 |
| Discovery Partners International Presents At Thomas Weisel Partners Healthcare Tailwinds 2001 Conference; Tuesday, April 3 at 3:20 pm PDT |
29-Mar-2001 |
| Discovery Partners International, Inc. to Acquire Xenometrix, Inc.; DPII Strengthens its Gene Expression Profiling Capabilities |
28-Feb-2001 |
| Discovery Partners International Presents At Lehman Brothers Annual ``Global Healthcare Conference;'' Wednesday, Feb. 28 at 11:15 a.m. Eastern Time |
22-Feb-2001 |
| Discovery Partners International Inc. Reports Fourth Quarter and Year End 2000 Financial Results; DPII Reports Record Revenues |
15-Feb-2001 |
| Discovery Partners International Announces Live Public Webcast of Fourth Quarter Earnings and Year End 2000 Results Conference Call |
7-Feb-2001 |
| Discovery Partners International Presents At 19th Annual J.P. Morgan H&Q Healthcare Conference; Monday, January 8 At 9:30 AM Pacific Time |
8-Jan-2001 |
| Discovery Partners International Presents At 19th Annual J.P. Morgan H&Q Healthcare Conference; Monday, January 8 At 9:30 AM Pacific Time |
5-Jan-2001 |
| Discovery Partners International, Inc. Agrees to Acquire SIDDCO, Combinatorial Chemistry Drug Discovery Company |
21-Dec-2000 |
| Discovery Partners Reports Record Revenues for Third Quarter 2000; Delivers First Two NanoKan Systems to Aventis and Bristol-Myers Squibb |
31-Oct-2000 |
| Discovery Partners International Announces Live Public Webcast of Third Quarter 2000 Earnings Conference Call |
31-Oct-2000 |
 |
